Trial reportScientific reports2025
Post-hoc mediation analysis of two biomarkers, and survival in acute respiratory distress syndrome.
Trial report in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Neuropilin-1 enriched mesenchymal stem cell derived-exosomes alleviate vascular hyperpermeability in acute lung injury.Extracellular vesicles and circulating nucleic acids · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Previous studies have shown that plasma soluble receptor for advanced glycation end-products (sRAGE) and the radiographic assessment of lung edema (RALE) are associated with the severity of acute respiratory distress syndrome (ARDS) both at baseline and over time. This study aims to explore the causal relationships among sRAGE, the RALE score, their fluctuations, and 90-day survival. Causal mediation analysis was conducted as a secondary analysis of the randomized controlled lung imaging for ventilator setting in ARDS (LIVE) trial, which assessed a mechanical ventilation strategy based on lung morphology. The primary outcome was survival at day 90. We used group-based trajectory modeling to summarize the biomarker patterns over time, followed by mediation analysis with the sRAGE and RALE score as mediators. Out of 400 patients in the LIVE study, 115 were included, resulting in three trajectory groups for both sRAGE and RALE. The mechanical ventilation strategy appeared to influence survival directly and indirectly: one indirect effect was mediated by one RALE score trajectory (aligning with the direct effect), and another by one sRAGE trajectory (opposing the direct effect). Both plasma sRAGE and the RALE score appeared to exhibit a mediation effect on survival for specific patient clusters. Identifying these clusters and using biomarkers as surrogate endpoints warrants further investigation in precision ARDS trials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.